UK Health & Social Care: M&A Sector Trends
UK Health & Social Care: M&A Sector Trends
The report covers deal volumes for the sector overall, and also the key sub-sectors of elderly care, adult specialist care, children care & specialist education, and domiciliary care.
What does the report cover?
- Current Market Dynamics
- Elderly care
- Adult and Children specialist care
- What is on the investor’s agenda
- What should be on the healthcare leader’s agenda
- Tax efficiencies
- What to do if you are facing challenges
Headlines
Overall, the sector has demonstrated its resilience and fundamental ability to deliver high quality care for the most vulnerable in society. This is underpinned by the growing demand for healthcare services and the sector’s ability to respond to the ongoing challenges of COVID and the more recent backdrop of inflationary pressures, labour shortages and rising cost of capital.
In 2022, deal volumes across elderly and specialist largely returned to pre-COVID levels, but the growth stalled between Q4 2022 to H1 2023 as the sector had to contend with an array of economic pressures. As these headwinds begin to alleviate, we are anticipating increasing investor appetite for high quality businesses and transaction activity returning.
The implementation of technology is becoming more prevalent in the industry with operators and investors appreciating the efficiencies and cost savings offered. This is an exciting part of the sector’s growth and development in the short to medium term.
Continued consolidation offers a route to manage the inflationary environment and deliver efficiencies. Consolidation remains a key growth strategy for many in the sector, and we see ‘buy and build’ strategies continuing in the foreseeable future.
Quality remains fundamental. Operators that are able to achieve high quality ratings are able to attract greater occupancy and fees, in turn leading to greater investor interest.
There is a broader requirement to concentrate on ESG, with sector leaders understanding this requires specific focus. The sector clearly leads on social impact, but all ‘ESG’ elements need development, and clear evidence of this is increasingly required by all stakeholders and funders.
Overall, despite the challenges, this key sector of our economy is set to continue to deliver the fundamental care provision needed across age groups and conditions. It has demonstrated its resilience and investors clearly remain attracted by the combination of the fundamental drivers of the sector, combined with operators focused on delivering successful business plans in changing times.
Who to contact for support:
- Helen O’Kane, Corporate Finance Partner – M&A, Health & Social Care
- Kerry Bailey, Partner – Business Restructuring, Health & Social Care
- Vicky Robertson, Tax Principal – Corporate Tax Services, Health & Social Care
- Gurpal Ahluwalia, National Head of M&A, Strategy and Commercial, Life Sciences | Health & Social Care
- Ishpal Bedi, Assistant Director, M&A, Health & Social Care